Recovery of brain dopamine metabolism by branched-chain amino acids in rats with acute hepatic failure

Journal of Neurosurgical Anesthesiology

Volumn 19, Issue 4, 2007, Pages 243-248

  Deshpande, Gautam ^a   Adachi, Naoto ^b   Liu, Keyue ^b   Motoki, Atsuko ^b   Mitsuyo, Toshihiko ^b   Nagaro, Takumi ^b   Arai, Tatsuru ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute liver failure; Branched chain amino acids; Dopamine; Hepatic encephalopathy; Rat

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BRANCHED CHAIN AMINO ACID; DOPAMINE; ISOLEUCINE; LEUCINE; LIVER ENZYME; MONOAMINE; NEUROTRANSMITTER; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; ENZYME BLOOD LEVEL; EXTRACELLULAR SPACE; HEPATIC ARTERY; HEPATIC ENCEPHALOPATHY; LIVER FAILURE; LIVER INJURY; LIVER ISCHEMIA; METABOLITE; MICRODIALYSIS; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; REPERFUSION;

3,4-DIHYDROXYPHENYLACETIC ACID; ALANINE TRANSAMINASE; AMINO ACIDS; AMINO ACIDS, BRANCHED-CHAIN; AMMONIA; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BRAIN CHEMISTRY; DOPAMINE; HYDROXYINDOLEACETIC ACID; ISCHEMIA; LIVER CIRCULATION; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; MALE; MICRODIALYSIS; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR; SEROTONIN;

EID: 34748834609     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31811ecdf6     Document Type: Article

References (28)

1. James JH. Branch chain amino acids in hepatic encephalopathy. Am J Surg. 2002;183:424-429.
2. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic encephalopathy. Lancet. 1971;2:75-80.
3. James JH, Ziparo V, Jeppsson B, et al. Hyperammonemia, plasma amino acid imbalance and blood-brain amino acid transport: a unified theory of portal-systemic encephalopathy. Lancet. 1979;2:772-775.
4. Fischer JE, Rosen HM, Ebeid AM, et al. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976;80:77-91.
5. Rosen M, Yoshimura N, Hodgman JM, et al. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology. 1977;72:483-487.
6. Ferenci P, Wewalka F. Plasma amino acids in hepatic encephalopathy. J Neural Transm. 1978;14(suppl):87-94.
7. Morgan MY, Milsom JP, Sherlock S. Plasma ratio of valine, leucine, and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 1978;19:1068-1073.
8. Ferenci P. Critical evaluation of the role of branched chain amino acids in liver disease. In: Thomas JC, Jones EA, eds. Recent Advances in Hepatology. New York: Churchill Livingstone; 1986:137.
9. Horst D, Grace ND, Conn HO, et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology. 1984;4:279-287.
10. Naylor CD, O'Rourke K, Detsky AS, et al. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology. 1989;97:1033-1042.
11. Marchesini G, Bianchi G, Zoli M. Oral BCAA in the treatment of chronic hepatic encephalopathy. J Hepatol. 1991;12:267.
12. Marchesini G, Bianchi G, Merli M, et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind, casein-controlled trial. Gastroenterology. 2003;124:1792-1801.
13. Muto Y, Sato S, Watanabe A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3:705-713.
14. Weissenborn K, Berding G, Kostler H. Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metabolic Brain Dis. 2000;15:173-178.
15. Waskiewicz S, Fresko I, Lenkiewicz A, et al. Reversible decrease of dopamine D2 receptor density in the striatum of rats with acute hepatic failure. Brain Res. 2001;900:143-145.
16. Pidoplichko VI, Dani JA. Acid-sensitive ionic channels in mid-brain dopamine neurons are sensitive to ammonium, which may contribute to hyperammonia damage. Proceeds Natl Acad Sci USA. 2006;103:11376-11380.
17. Yano M, Adachi N, Liu K, et al. Flumazenil-induced improvement of the central dopaminergic system in rats with acute hepatic failure. J Neurosurg Anesthesiol. 2005;17:69-74.
18. Adachi N, Inoue H, Arai T. Changes in the brain monoamine metabolism in acute liver failure produced by ischemia-reperfusion injury in rats. Crit Care Med. 1998;26:717-722.
19. Als-Nielsen B, Koretz RL, Kjaegard LL, et al. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003;2:CD001939.
20. Iwasa M, Matsumura K, Watanabe Y, et al. Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2003;15:733-737.
21. Higuchi K, Shimizu Y, Nambu S. Effects of an infusion of branched-chain amino acids on neurophysiological and psychometric testings in cirrhotic patients with mild hepatic encephalopathy. J Gastroenterol Hepatol. 1994;4:366-372.
22. Grippon P, Le Poncin Lafitte M, Boschat M, et al. Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan. Hepatology. 1986;6:682-686.
23. Arai K, Lee K, Berthiaume F, et al. Intrahepatic amino acid and glucose metabolism in a D-galactose-induced rat liver failure model. Hepatology. 2001;2:360-371.
24. +-independent systems. J Biol Chem. 1983;258:8949-8954.
25. Butterworth RF. Evidence that hepatic encephalopathy results from a defect of glutamatergic synaptic regulation. Mol Neuropharmacol. 1992;2:229-232.
26. Bengtsson F, Nobin A, Falck B, et al. Portocaval shunt in the rat: selective alterations in behavior and brain serotonin. Pharmacol Biochem Behav. 1986;24:1611-1616.
27. Bengtsson F, Bugge M, Hansson L, et al. Serotonin metabolism in the central nervous system following sepsis or portocaval shunt in the rat. J Surg Res. 1987;43:420-429.
28. Bergqvist PB, Bosman DK, Maas MA, et al. Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. J Neurochem. 1995;64:1238-1244.